A Study of SPY002-072 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

April 3, 2026

Study Completion Date

August 8, 2026

Conditions

Healthy

Interventions

DRUG

SPY002-072

Experimental

OTHER

Placebo

Trial Locations (2)

NOT_YET_RECRUITING

Spyre Site 2, Cypress

RECRUITING

Spyre Site 1, Montreal

All Listed Sponsors

collaborator

Altasciences Company Inc.

INDUSTRY

lead

Spyre Therapeutics, Inc.

INDUSTRY